Category: Mergers & AcquisitionsSyndicate content

Invacare unloads rehab devices for $23M

September 2, 2014 by Arezu Sarvestani

Invacare sells its Altimate Medical subsidiary, maker of standing-assistance devices, to Rockwood Equity Partners for about $23 million in cash.

Invacare unloads rehab devices for $23M

Invacare (NYSE:IVC) is hoping to narrow its focus and reduce its debt after divesting its Altimate Medical subsidiary for $23 million in cash.

Boston Scientific closes $415 Bayer interventions buy

September 2, 2014 by Brad Perriello

Boston Scientific says it's closed the $415 million acquisition of Bayer AG's interventions unit, nearly doubling the size of its peripherals business.

Boston Scientific closes $415 Bayer interventions buy

Boston Scientific (NYSE:BSX) said today that it closed on the $415 million cash buyout of Bayer AG's interventional unit it announced last May.

Report: J&J puts Cordis on the block

August 29, 2014 by Arezu Sarvestani

Johnson & Johnson puts its Cordis vascular device business on the auction block after years of sluggish growth.

Report: J&J's selling its Cordis division

Healthcare giant Johnson & Johnson (NYSE:JNJ) is looking to divest its Cordis business after years of lackluster sales for the company's stents, catheters and other vascular devices, according to a report from the Wall Street Journal.

Medtronic to cover $58M tax tab for top execs in Covidien buy

August 29, 2014 by Brad Perriello

Medtronic reveals that the tax tab for its top executives from its Covidien buyout will near $58 million, apart from the capital gains taxes all shareholders will pay on the $43 billion deal.

Medtronic to cover $58M tax tab for top execs in Covidien buy

Covidien acquires Sapheon and its VenaSeal varicose vein treatment

August 28, 2014 by Brad Perriello

Covidien acquires Sapheon and its minimally invasive VenaSeal device for treating varicose veins for an undisclosed amount.

Covidien acquires Sapheon and its VenaSeal varicose vein treatment

Allergan accedes to special meeting, asks court to block Valeant's vote

August 27, 2014 by Arezu Sarvestani

Botox-maker Allergan acquiesces to Valeant Pharmaceuticals' demands for a special shareholder meeting, but takes to court to prevent Valeant and its compatriots from voting their shares.

Allergan accedes to special meeting, asks court to block Valeant's vote

Another Covidien shareholder sues over Medtronic deal

August 27, 2014 by Arezu Sarvestani

Yet another shareholder sues Covidien and its leaders, accusing them of short-changing investors in the $43 billion acquisition by Medtronic.

Another Covidien shareholder sues over Medtronic deal
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp